Considerations on the design of lipid-based mRNA vaccines against cancer
- Author
- Sofie Meulewaeter (UGent) , Yao Zhang, Abishek Wadhwa, Kevin Fox, Ine Lentacker (UGent) , Kenneth W. Harder, Pieter R. Cullis, Stefaan De Smedt (UGent) , Miffy H.Y. Cheng and Rein Verbeke (UGent)
- Organization
- Project
-
- Understanding and modulating the pro-inflammatory activity of lipid nanoparticles (LNP) in the COVID-19 mRNA vaccines: towards the development of more effective LNP formulations.
- Further development of mRNA Galsomes as nanovaccines for cancer immunotherapy: combination with checkpoint inhibition and translation to the clinic.
- Immunopeptidomics-based Development of Next-Generation Bacterial mRNA Vaccines
- Vaccination with nucleoside-modified mRNA-ceramide lipoplexes: a phase I trial in stage IV lung carcinoma patients
- Proteomics-derived epitopes for dramatically improved anticancer and antibacterial vaccine development
- Keywords
- Molecular Biology, Structural Biology, cancer vaccines, lipid nanoparticles, lipoplexes, mRNA vaccine, innate immunity, CATIONIC LIPIDS, T-CELLS, LIPOPLEX VACCINES, STRUCTURAL BASIS, CO-DELIVERY, IN-VIVO, NANOPARTICLES, TRIAL, TRANSLATION, IMMUNOGENICITY
Downloads
-
20231218 JMB Revised review.pdf
- full text (Accepted manuscript)
- |
- open access
- |
- |
- 1.72 MB
-
(...).pdf
- full text (Published version)
- |
- UGent only
- |
- |
- 1.69 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01HQK1FAEW70VQ00X45ZMWQY5B
- MLA
- Meulewaeter, Sofie, et al. “Considerations on the Design of Lipid-Based MRNA Vaccines against Cancer.” JOURNAL OF MOLECULAR BIOLOGY, vol. 436, no. 2, 2024, doi:10.1016/j.jmb.2023.168385.
- APA
- Meulewaeter, S., Zhang, Y., Wadhwa, A., Fox, K., Lentacker, I., Harder, K. W., … Verbeke, R. (2024). Considerations on the design of lipid-based mRNA vaccines against cancer. JOURNAL OF MOLECULAR BIOLOGY, 436(2). https://doi.org/10.1016/j.jmb.2023.168385
- Chicago author-date
- Meulewaeter, Sofie, Yao Zhang, Abishek Wadhwa, Kevin Fox, Ine Lentacker, Kenneth W. Harder, Pieter R. Cullis, Stefaan De Smedt, Miffy H.Y. Cheng, and Rein Verbeke. 2024. “Considerations on the Design of Lipid-Based MRNA Vaccines against Cancer.” JOURNAL OF MOLECULAR BIOLOGY 436 (2). https://doi.org/10.1016/j.jmb.2023.168385.
- Chicago author-date (all authors)
- Meulewaeter, Sofie, Yao Zhang, Abishek Wadhwa, Kevin Fox, Ine Lentacker, Kenneth W. Harder, Pieter R. Cullis, Stefaan De Smedt, Miffy H.Y. Cheng, and Rein Verbeke. 2024. “Considerations on the Design of Lipid-Based MRNA Vaccines against Cancer.” JOURNAL OF MOLECULAR BIOLOGY 436 (2). doi:10.1016/j.jmb.2023.168385.
- Vancouver
- 1.Meulewaeter S, Zhang Y, Wadhwa A, Fox K, Lentacker I, Harder KW, et al. Considerations on the design of lipid-based mRNA vaccines against cancer. JOURNAL OF MOLECULAR BIOLOGY. 2024;436(2).
- IEEE
- [1]S. Meulewaeter et al., “Considerations on the design of lipid-based mRNA vaccines against cancer,” JOURNAL OF MOLECULAR BIOLOGY, vol. 436, no. 2, 2024.
@article{01HQK1FAEW70VQ00X45ZMWQY5B,
articleno = {{168385}},
author = {{Meulewaeter, Sofie and Zhang, Yao and Wadhwa, Abishek and Fox, Kevin and Lentacker, Ine and Harder, Kenneth W. and Cullis, Pieter R. and De Smedt, Stefaan and Cheng, Miffy H.Y. and Verbeke, Rein}},
issn = {{0022-2836}},
journal = {{JOURNAL OF MOLECULAR BIOLOGY}},
keywords = {{Molecular Biology,Structural Biology,cancer vaccines,lipid nanoparticles,lipoplexes,mRNA vaccine,innate immunity,CATIONIC LIPIDS,T-CELLS,LIPOPLEX VACCINES,STRUCTURAL BASIS,CO-DELIVERY,IN-VIVO,NANOPARTICLES,TRIAL,TRANSLATION,IMMUNOGENICITY}},
language = {{eng}},
number = {{2}},
pages = {{21}},
title = {{Considerations on the design of lipid-based mRNA vaccines against cancer}},
url = {{http://doi.org/10.1016/j.jmb.2023.168385}},
volume = {{436}},
year = {{2024}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: